Compugen to Release Fourth Quarter and Full Year 2022 Results on Monday, February 27, 2023
HOLON, Israel, Feb. 13, 2023 /PRNewswire/ -- Compugen Ltd. , a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced that the Company will... | February 13, 2023